tiprankstipranks
Trending News
More News >
Metagenomi, Inc. (MGX)
NASDAQ:MGX
US Market

Metagenomi, Inc. (MGX) Stock Statistics & Valuation Metrics

Compare
894 Followers

Total Valuation

Metagenomi, Inc. has a market cap or net worth of $63.17M. The enterprise value is $143.06M.
Market Cap$63.17M
Enterprise Value$143.06M

Share Statistics

Metagenomi, Inc. has 37,381,496 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding37,381,496
Owned by Insiders8.11%
Owned by Institutions9.43%

Financial Efficiency

Metagenomi, Inc.’s return on equity (ROE) is -0.33 and return on invested capital (ROIC) is -28.35%.
Return on Equity (ROE)-0.33
Return on Assets (ROA)-0.24
Return on Invested Capital (ROIC)-28.35%
Return on Capital Employed (ROCE)-0.31
Revenue Per Employee258.89K
Profits Per Employee-386.43K
Employee Count202
Asset Turnover0.16
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Metagenomi, Inc. is -1.73. Metagenomi, Inc.’s PEG ratio is -0.07.
PE Ratio-1.73
PS Ratio0.00
PB Ratio-4.15
Price to Fair Value0.58
Price to FCF19.62
Price to Operating Cash Flow10.39
PEG Ratio-0.07

Income Statement

In the last 12 months, Metagenomi, Inc. had revenue of 52.30M and earned -78.06M in profits. Earnings per share was -2.36.
Revenue52.30M
Gross Profit52.30M
Operating Income-88.90M
Pretax Income-83.57M
Net Income-78.06M
EBITDA-83.49M
Earnings Per Share (EPS)-2.36

Cash Flow

In the last 12 months, operating cash flow was -102.06M and capital expenditures -2.49M, giving a free cash flow of -104.55M billion.
Operating Cash Flow-102.06M
Free Cash Flow-104.55M
Free Cash Flow per Share-2.80

Dividends & Yields

Metagenomi, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.11
52-Week Price Change-61.50%
50-Day Moving Average1.60
200-Day Moving Average2.12
Relative Strength Index (RSI)58.69
Average Volume (3m)535.31K

Important Dates

Metagenomi, Inc. upcoming earnings date is Aug 13, 2025, Before Open (Confirmed).
Last Earnings DateMay 13, 2025
Next Earnings DateAug 13, 2025
Ex-Dividend Date

Financial Position

Metagenomi, Inc. as a current ratio of 6.91, with Debt / Equity ratio of -24.95%
Current Ratio6.91
Quick Ratio6.91
Debt to Market Cap0.00
Net Debt to EBITDA-0.22
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Metagenomi, Inc. has paid -5.51M in taxes.
Income Tax-5.51M
Effective Tax Rate0.07

Enterprise Valuation

Metagenomi, Inc. EV to EBITDA ratio is -1.84, with an EV/FCF ratio of -1.37.
EV to Sales2.93
EV to EBITDA-1.84
EV to Free Cash Flow-1.37
EV to Operating Cash Flow-1.41

Balance Sheet

Metagenomi, Inc. has $225.97M in cash and marketable securities with $44.44M in debt, giving a net cash position of -$181.53M billion.
Cash & Marketable Securities$225.97M
Total Debt$44.44M
Net Cash-$181.53M
Net Cash Per Share-$4.86
Tangible Book Value Per Share$6.28

Margins

Gross margin is 89.92%, with operating margin of -170.00%, and net profit margin of -149.26%.
Gross Margin89.92%
Operating Margin-170.00%
Pretax Margin-159.81%
Net Profit Margin-149.26%
EBITDA Margin-159.66%
EBIT Margin-170.00%

Analyst Forecast

The average price target for Metagenomi, Inc. is $10.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$10.33
Price Target Upside518.56% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast-4.22%
EPS Growth Forecast18.67%

Scores

Smart Score4
AI Score52
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis